Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

574 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Determinants of gliadin-specific T cell selection in celiac disease.
Petersen J, van Bergen J, Loh KL, Kooy-Winkelaar Y, Beringer DX, Thompson A, Bakker SF, Mulder CJ, Ladell K, McLaren JE, Price DA, Rossjohn J, Reid HH, Koning F. Petersen J, et al. Among authors: mulder cj. J Immunol. 2015 Jun 15;194(12):6112-22. doi: 10.4049/jimmunol.1500161. Epub 2015 May 6. J Immunol. 2015. PMID: 25948817
Origin and immunophenotype of aberrant IEL in RCDII patients.
Tack GJ, van Wanrooij RL, Langerak AW, Tjon JM, von Blomberg BM, Heideman DA, van Bergen J, Koning F, Bouma G, Mulder CJ, Schreurs MW. Tack GJ, et al. Among authors: mulder cj. Mol Immunol. 2012 Apr;50(4):262-70. doi: 10.1016/j.molimm.2012.01.014. Epub 2012 Feb 23. Mol Immunol. 2012. PMID: 22364936
Gluten-free diet in gluten-related disorders.
Mulder CJ, van Wanrooij RL, Bakker SF, Wierdsma N, Bouma G. Mulder CJ, et al. Dig Dis. 2013;31(1):57-62. doi: 10.1159/000347180. Epub 2013 Jun 17. Dig Dis. 2013. PMID: 23797124 Review.
Therapy in RCDII: Rationale for Combination Strategies?
Nijeboer P, Malamut G, Bouma G, Cerf-Bensussan N, Koning F, van Bergen J, Cellier C, Mulder CJJ. Nijeboer P, et al. Dig Dis. 2015;33(2):227-230. doi: 10.1159/000381076. Epub 2015 Apr 22. Dig Dis. 2015. PMID: 25925927 Review.
Antibody titers against food antigens decrease upon a gluten-free diet, but are not useful for the follow-up of (refractory) celiac disease.
Gross S, van Wanrooij RL, Tack GJ, Gelderman KA, Bakker SF, van Hoogstraten IM, Neefjes-Borst EA, Schreurs MW, Bouma G, Mulder CJ, von Blomberg BM, Bontkes HJ. Gross S, et al. Among authors: mulder cj. Eur J Gastroenterol Hepatol. 2013 Apr;25(4):516-8. doi: 10.1097/MEG.0b013e32835dca77. Eur J Gastroenterol Hepatol. 2013. PMID: 23337171 No abstract available.
Cladribine therapy in refractory celiac disease with aberrant T cells.
Al-Toma A, Goerres MS, Meijer JW, von Blomberg BM, Wahab PJ, Kerckhaert JA, Mulder CJ. Al-Toma A, et al. Among authors: mulder cj. Clin Gastroenterol Hepatol. 2006 Nov;4(11):1322-7; quiz 1300. doi: 10.1016/j.cgh.2006.07.007. Epub 2006 Sep 18. Clin Gastroenterol Hepatol. 2006. PMID: 16979946 Clinical Trial.
Flow cytometric determination of aberrant intra-epithelial lymphocytes predicts T-cell lymphoma development more accurately than T-cell clonality analysis in Refractory Celiac Disease.
Verbeek WH, Goerres MS, von Blomberg BM, Oudejans JJ, Scholten PE, Hadithi M, Al-Toma A, Schreurs MW, Mulder CJ. Verbeek WH, et al. Among authors: mulder cj. Clin Immunol. 2008 Jan;126(1):48-56. doi: 10.1016/j.clim.2007.09.002. Epub 2007 Nov 26. Clin Immunol. 2008. PMID: 18024205
The MYO9B gene is a strong risk factor for developing refractory celiac disease.
Wolters VM, Verbeek WH, Zhernakova A, Onland-Moret C, Schreurs MW, Monsuur AJ, Verduijn W, Wijmenga C, Mulder CJ. Wolters VM, et al. Among authors: mulder cj. Clin Gastroenterol Hepatol. 2007 Dec;5(12):1399-405, 1405.e1-2. doi: 10.1016/j.cgh.2007.08.018. Epub 2007 Oct 29. Clin Gastroenterol Hepatol. 2007. PMID: 17967566
574 results